7 completed, 1 unknown. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 7, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow SmithKline Beecham: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma Topotecan, Cyclophosphamide, Melphalan - Myeloma | Phase 2 | Completed | M.D. Anderson Cancer Center | 60 | 2002-02-18 | 2018-11-07 |
| An Evaluation of Weekly Tafenoquine Tafenoquine, Mefloquine, Placebo - Falciparum Parasitaemia | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 306 | 2000-05-01 | 2017-05-30 |
| A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide Cytarabine, Daunorubicin, Etoposide - Leukemia | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 41 | 1999-07-01 | 2012-09-25 |
| A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum Placebo, Tafenoquine 25mg, Tafenoquine 50mg - Malaria | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 521 | 1998-08-01 | 2018-09-13 |
| Use of Topotecan in Patients With Refractory Acute Leukemia Topotecan, Mitozantrone, Etoposide - Non-Hodgkin's Lymphoma, Leukemia | Phase 2 | Completed | US Department of Veterans Affairs | 10 | 1998-08-01 | 2013-09-25 |
| Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer carboplatin, paclitaxel, topotecan hydrochloride - Ovarian Cancer | Phase 2 | Unknown | SmithKline Beecham | 40 | 1997-12-01 | 2013-09-20 |
| Evaluation of Weekly Tafenoquine Tafenoquine, Placebo - Malaria | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 249 | 1997-05-01 | 2018-09-13 |
| Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML) Topotecan - HIV Infections, Leukoencephalopathy, Progressive Multifocal | Phase 2 | Completed | SmithKline Beecham | 54 | 2005-06-24 |
Malaria (3) · Leukemia (2) · AIDS-Related Opportunistic Infections (1) · Carcinoma, Ovarian Epithelial (1) · Congenital Abnormalities (1) · HIV Infections (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Leukoencephalopathy, Progressive Multifocal (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Topotecan (5) · tafenoquine (3) · Etoposide (2) · Mefloquine (2) · Carboplatin (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Melphalan (1) · Mitoxantrone (1) · Paclitaxel (1)
United States (4) · United Kingdom (1)
A.J Oloo (1) · Braden Hale, MD (1) · Gordon J.S. Rustin, MD (1) · Hussain I. Saba, MD, PhD (1) · Jose Stoute, MD (1) · Mark Mainwaring (1) · Michelle Donato, MD (1)